Favorable outcomes of DDX41-mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide
- Author(s)
- Tiong, IS; Stevenson, WS; Wall, M; Yap, YZ; Seymour, JF; Kenealy, M; Blombery, P; Australasian Leukaemia & Lymphoma Group;
- Details
- Publication Year 2023-11,Volume 4,Issue #4,Page 1212-1215
- Journal Title
- eJHaem
- Publication Type
- Research article
- Department(s)
- Pathology; Clinical Haematology
- Publisher's Version
- https://doi.org/10.1002/jha2.767
- Open Access at Publisher's Site
https://doi.org/10.1002/jha2.767- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-01-04 02:56:44
Last Modified: 2024-01-04 02:57:34